Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Margareth Roch
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Procedures
Anatomy
Physiology
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
30
Jenden, Donald
10
Buchman, Alan
6
Scremin, Oscar
5
Ament, Marvin
4
Huynh, Ly
4
Shih, Tsung-Ming
3
Sohel, M
3
Sun, Wei
3
Ahn, Chul
3
Awal, M
2
Chialvo, Dante
2
Waite, Jerene
1
Misra, Sudipta
1
Belfort, Michael
1
Capdevila, Antonieta
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Margareth Roch (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2006: Scremin Oscar U; Li Mingen Grace; Roch Margareth; Booth Ruth; Jenden Donald J
Acetylcholine and choline dynamics provide early and late markers of traumatic brain injury.
Brain research 2006;1124(1):155-66.
-
2006: Shih Tsung-Ming; Scremin Oscar U; Roch Margareth; Huynh Ly; Sun Wei; Jenden Donald J
Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats.
Archives of toxicology 2006;80(11):761-7.
-
2006: Scremin Oscar U; Shih Tsung-Ming; Huynh Ly; Roch Margareth; Sun Wei; Chialvo Dante R; Jenden Donald J
Circadian rhythms of heart rate and locomotion after treatment with low-dose acetylcholinesterase inhibitors.
Journal of applied toxicology : JAT 2006;26(5):410-8.
-
2005: Scremin Oscar U; Shih Tsung-Ming; Huynh Ly; Roch Margareth; Sun Wei; Chialvo Dante R; Jenden Donald J
Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism.
Pharmacology, biochemistry, and behavior 2005;80(4):529-40.
-
2003: Scremin Oscar U; Shih Tsung-Ming; Huynh Ly; Roch Margareth; Booth Ruth; Jenden Donald J
Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors.
The Journal of pharmacology and experimental therapeutics 2003;304(3):1111-9.
-
2001: Buchman A L; Ament M E; Sohel M; Dubin M; Jenden D J; Roch M; Pownall H; Farley W; Awal M; Ahn C
Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial.
JPEN. Journal of parenteral and enteral nutrition 2001;25(5):260-8.
-
2001: Buchman A L; Sohel M; Brown M; Jenden D J; Ahn C; Roch M; Brawley T L
Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study.
JPEN. Journal of parenteral and enteral nutrition 2001;25(1):30-5.
-
2001: Buchman A L; Sohel M; Moukarzel A; Bryant D; Schanler R; Awal M; Burns P; Dorman K; Belfort M; Jenden D J; Killip D; Roch M
Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition.
Nutrition (Burbank, Los Angeles County, Calif.) 2001;17(1):18-21.
-
2000: Mudd S H; Jenden D J; Capdevila A; Roch M; Levy H L; Wagner C
Isolated hypermethioninemia: measurements of S-adenosylmethionine and choline.
Metabolism: clinical and experimental 2000;49(12):1542-7.
-
2000: Buchman A L; Awal M; Jenden D; Roch M; Kang S H
The effect of lecithin supplementation on plasma choline concentrations during a marathon.
Journal of the American College of Nutrition 2000;19(6):768-70.
-
2000: Buchman A L; Jenden D; Suki W N; Roch M
Changes in plasma free and phospholipid-bound choline concentrations in chronic hemodialysis patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2000;10(3):133-8.
-
1999: Buchman A L; Jenden D; Roch M
Plasma free, phospholipid-bound and urinary free choline all decrease during a marathon run and may be associated with impaired performance.
Journal of the American College of Nutrition 1999;18(6):598-601.
-
1999: Misra S; Ahn C; Ament M E; Choi H J; Jenden D J; Roch M; Buchman A L
Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study.
JPEN. Journal of parenteral and enteral nutrition 1999;23(5):305-8.
-
1996: Jenden D J; Scremin O U; Roch M; Li G
The influence of aging on whole body choline release and clearance.
Life sciences 1996;58(22):2003-9.
-
1995: Buchman A L; Dubin M D; Moukarzel A A; Jenden D J; Roch M; Rice K M; Gornbein J; Ament M E
Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation.
Hepatology (Baltimore, Md.) 1995;22(5):1399-403.
-
1994: Buchman A L; Jenden D J; Moukarzel A A; Roch M; Rice K M; Chang A S; Ament M E
Choline pharmacokinetics during intermittent intravenous choline infusion in human subjects.
Clinical pharmacology and therapeutics 1994;55(3):277-83.
-
1992: Buchman A L; Dubin M; Jenden D; Moukarzel A; Roch M H; Rice K; Gornbein J; Ament M E; Eckhert C D
Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients.
Gastroenterology 1992;102(4 Pt 1):1363-70.
-
1992: Russell R W; Booth R A; Jenden D J; Chang A S; Rice K M; Roch M; Lauretz S D
Incomplete reversibility of an experimentally induced hypocholinergic state: biochemical and physiological, but not behavioral, recovery.
Pharmacology, biochemistry, and behavior 1992;41(2):433-44.
-
1990: Russell R W; Jenden D J; Booth R A; Lauretz S D; Rice K M; Roch M
Global in vivo replacement of choline by N-aminodeanol. Testing a hypothesis about progressive degenerative dementia: II. Physiological and behavioral effects.
Pharmacology, biochemistry, and behavior 1990;37(4):811-20.
-
1990: Knusel B; Jenden D J; Lauretz S D; Booth R A; Rice K M; Roch M; Waite J J
Global in vivo replacement of choline by N-aminodeanol. Testing a hypothesis about progressive degenerative dementia: I. Dynamics of choline replacement.
Pharmacology, biochemistry, and behavior 1990;37(4):799-809.
-
1990: Ringdahl B; Mellin C; Ehlert F J; Roch M; Rice K M; Jenden D J
Tertiary 2-haloethylamine derivatives of the muscarinic agent McN-A-343, [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Journal of medicinal chemistry 1990;33(1):281-6.
-
1990: Jenden D J; Rice K M; Roch M; Booth R A; Lauretz S D
Effects of nicotinamide on choline and acetylcholine levels in rats.
Advances in neurology 1990;51():131-8.
-
1989: Russell R W; Booth R A; Smith C A; Jenden D J; Roch M; Rice K M; Lauretz S D
Roles of neurotransmitter receptors in behavior: recovery of function following decreases in muscarinic receptor density induced by cholinesterase inhibition.
Behavioral neuroscience 1989;103(4):881-92.
-
1989: Ringdahl B; Katz E D; Roch M; Jenden D J
Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
The Journal of pharmacology and experimental therapeutics 1989;249(1):210-5.
-
1989: Ringdahl B; Roch M; Katz E D; Frankland M C
Alkylating partial muscarinic agonists related to oxotremorine. N-[4-[(2-haloethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidones.
Journal of medicinal chemistry 1989;32(3):659-63.
-
1989: Jenden D J; Russell R W; Booth R A; Knusel B J; Lauretz S D; Rice K M; Roch M
Effects of chronic in vivo replacement of choline with a false cholinergic precursor.
EXS 1989;57():229-35.
-
1988: Ringdahl B; Roch M; Jenden D J
Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists.
Journal of medicinal chemistry 1988;31(1):160-4.
-
1987: Ringdahl B; Roch M; Jenden D J
Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
The Journal of pharmacology and experimental therapeutics 1987;242(2):464-71.
-
1987: Jenden D J; Russell R W; Booth R A; Lauretz S D; Knusel B J; Roch M; Rice K M; George R; Waite J J
A model hypocholinergic syndrome produced by a false choline analog, N-aminodeanol.
Journal of neural transmission. Supplementum 1987;24():325-9.
-
1985: Amstutz R; Ringdahl B; Karlén B; Roch M; Jenden D J
Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.
Journal of medicinal chemistry 1985;28(12):1760-5.
-
1985: Russell R W; Booth R A; Jenden D J; Roch M; Rice K M
Changes in presynaptic release of acetylcholine during development of tolerance to the anticholinesterase, DFP.
Journal of neurochemistry 1985;45(1):293-9.
Sign-in to see more
